Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Hearne Michael S

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Hearne Michael S

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-12-27
Purchase
2018-12-31
5:17 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
63,700 $13.11 $835,107 12,946,038
(Indirect)
View
2018-12-20
Purchase
2018-12-26
6:21 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
60,000 $12.6 $755,857 12,882,338
(Indirect)
View
2018-12-14
Purchase
2018-12-18
5:58 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
40,000 $14.67 $586,639 12,822,338
(Indirect)
View
2018-12-11
Purchase
2018-12-13
8:18 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
20,000 $15.6 $312,073 12,782,338
(Indirect)
View
2018-12-06
Purchase
2018-12-10
6:24 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
20,000 $14.79 $295,864 12,762,338
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-01-15
Option Award
2019-01-17
7:15 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
40 $13.85 12,946,038
(Direct)
View
2019-01-15
Option Award
2019-01-17
7:15 pm
N/A
2029-01-15
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
40 $16.29 12,946,038
(Direct)
View
2018-12-31
Option Award
2019-01-03
8:10 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
45 $11.97 12,946,038
(Direct)
View
2018-12-31
Option Award
2019-01-03
8:10 pm
N/A
2028-12-31
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
45,045 $14.08 12,946,038
(Direct)
View
2018-12-14
Option Award
2018-12-18
6:00 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
42 $12.85 12,822,338
(Direct)
View
2018-12-14
Option Award
2018-12-18
6:00 pm
N/A
2028-12-14
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
42 $15.12 12,822,338
(Direct)
View
2018-11-30
Option Award
2018-12-04
6:27 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
40 $13.4 12,742,338
(Direct)
View
2018-11-30
Option Award
2018-12-04
6:27 pm
N/A
2028-11-30
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
40 $15.76 12,742,338
(Direct)
View